What does the Australian Border Force prohibited imports list mean for research peptides?
A border prohibited-imports list is a legal classification tool, not a purity specification and not a certificate of analysis. The laboratory question is whether the molecule in the vial, under the name on the purchase order, the commercial invoice or the internal substance register, corresponds to an entry an official instrument treats as prohibited, restricted or conditional. That match cannot be inferred from a fragment nickname, a three-letter code or a marketing line. It is built from sequence, counter-ion, labelled amount and lot identifier, then set against the wording of the instrument that was actually consulted.
Australian writing has long treated prohibited importation as a named category. A 1969 note in the Australian Psychologist discussed prohibited importation of professional literature (DOI:10.1080/00050066908257667). That note is not a peptide schedule. It shows a control addressed to a class of goods, not to the buyer's intention. An in vitro protocol does not take a peptide out of a named class. A domestic catalogue heading does not decide the border category of a foreign shipment.
Other prohibited lists show why the instrument name must be stored. A 2016 comment in Australian Prescriber discussed meldonium and the WADA Prohibited List (DOI:10.18773/austprescr.2016.032). A 2010 equine paper examined controversy about the FEI progressive list of prohibited substances (DOI:10.21836/pem20100225). Neither paper is an Australian Border Force instrument. The file should keep list name, issuing body and consultation date in separate fields. Pasting a sporting or equine entry into a customs column, or the reverse, creates a false concordance.
For research peptides, the identity block that precedes any list result contains the sequence or recognised analogue name, any terminal modification, the salt form (acetate, trifluoroacetate or another stated counter-ion), gross mass and, where reported, net peptide content, the lot number, and the exact string searched. A trade-name search against a chemical-name list is incomplete. Ambiguous hits remain ambiguous. They are not settled by the reading that makes procurement easier.
How should a laboratory keep a sporting prohibited list out of an import file?
List literacy is not guaranteed by job title or by proximity to a regulated activity. A laboratory should not assume that familiarity with a sporting prohibited list classifies a synthetic peptide for an import file. Record the search string, the date and the extract, not a recollection.
Lists change, and commentary exists because change is not self-explanatory. The Australian Prescriber comment on meldonium and the WADA Prohibited List is an example of professional discussion of a list amendment, not a border ruling (DOI:10.18773/austprescr.2016.032). A screening note that says only "checked against the prohibited list", with no date, version or captured official extract, is not reproducible. Retain a dated extract of the entry compared, including any class definition. If the entry uses a class phrase, quote that phrase and state why the peptide was judged inside or outside it, using the instrument's words. If that sentence cannot be written, the result is "not determined", not "absent".
Cross-regime borrowing is a separate error. Controversy about the FEI progressive list shows that prohibited-list design is contested even within sport, and that one federation's list is not another body's list (DOI:10.21836/pem20100225). A class name in one instrument does not donate scope to another. A shared nickname with a sporting-list substance does not place a peptide on a customs list. An equine amendment does not describe Australian import controls. Refuse analogy. Require the controlling instrument's own words, including any definition, exclusion or condition attached to the entry. If the words do not decide the question, code the result as not determined and hold the lot.
In the quality system, use a two-column register. Column A holds sporting or professional-conduct lists, and only if governance actually requires them. Column B holds import and scheduling controls relevant to bringing a substance into Australia. A hit in column A never auto-populates column B. Each column has its own date and reviewer initials. Neither column authorises importation, possession or supply.
Which analytical results stop a research peptide being misnamed on a record?
Misnaming is an analytical failure before it is a paperwork failure. Reversed-phase HPLC area-percent purity does not identify a peptide. A main peak at high area percent, integrated at 214 nm above a stated reporting threshold, shows that most UV-active material eluted at one retention time under that method. It does not prove sequence, and it does not prove salt. Identity for a classification file uses orthogonal evidence: intact mass inside a written window of the theoretical monoisotopic or average mass, and tandem fragments covering the claimed sequence, including terminal modifications. In a blend, each component needs its own mass assignment.
Salt form changes gross mass and can change the printed name. Acetate and trifluoroacetate salts of one backbone are different procurement items. A list search on the free-peptide name, while the vial and invoice state a salt, leaves a gap. The record states which string was searched and whether the salt was its own synonym line. Net peptide content, where reported, corrects water and counter-ion so a milligram figure is not read as backbone mass. It is not a legal exemption and not a synonym for HPLC purity. Purity, net peptide content and identity occupy three rows.
Related substances matter because a deletion, an insertion, a deamidated form or an incomplete side-chain modification may be what was weighed, while the label names the intended sequence. Searching the intended name against a lot whose mass does not match is a false search. Before any list result is signed, one lot identifier must appear on the vial, the certificate header and the mass-spectrometry sample name; observed mass must sit inside the laboratory window; peaks above the related-substance reporting threshold must be listed; and the chromatogram file identifier must be citable. If any item fails, list status is unsigned and the lot is held for identity work. It is not a reason to rename the goods.
How does an Australian stock file differ from an import classification file?
Domestic supply and importation are different record types, even when the molecule is the same. A domestic receipt file records the purchase order, lot number, vial count, certificate of analysis, chromatogram and mass-spectrometry identifiers, reviewer sign-off, and, if a courier was used, a consignment number. That file answers which lot was received and which analytical evidence was attached. It does not answer whether the substance is prohibited or restricted, whether a permit was required, or whether a foreign shipment was lawfully declared. Those questions must not share one checkbox. A domestic receipt is not a determination that importation would have been lawful.
Australian import composition has long been analysed as a data problem rather than as a single laboratory method. Kumar's review of Australian imports during the 1960s is a trade paper, not a customs manual (DOI:10.1111/j.1467-8462.1970.tb00090.x). A 1970 note asked whether Australian chemical supply would grow at home or by imports (DOI:10.1021/cen-v048n044.p048). Their only present use is narrow: the commercial path changes which records exist. Neither paper places any peptide on a current prohibited-imports list. No figure in them should be reused as a modern border statistic.
Supplier evaluation may record where the lot was held when the order was placed. Stock already in Australia can be matched to batch documentation on receipt. That is a traceability fact. It is not a claim that the peptide sits outside import, scheduling or possession controls, and it is not a substitute for reading the current official instrument when the buyer's system requires a classification. Import steps, permit pathways and declaration wording are not set out here. A milder description written to influence an entry is misdeclaration, and it sits outside laboratory practice and lawful procurement.
Net peptide content, counter-ion and fill mass change what a per-milligram figure means. A lower price on a gross-mass vial with unstated trifluoroacetate is not equivalent to a vial that reports net peptide content and acetate. A supplier line that goods are not prohibited is not evidence unless a dated official extract, in the publisher's words, matches that lot's name and salt. Otherwise status stays not determined. No catalogue page, dispatch note or research-use label replaces the official instrument. Materials are for research use only and are not for human use.
What belongs in a prohibited-list screening record for a peptide lot?
A prohibited-list screening record is a controlled form kept beside the certificate, not a line in a purchasing email. The header carries the laboratory substance identifier, the supplier name, the catalogue code and the lot number exactly as printed on the primary container. If the container uses a short code and the certificate uses a longer analogue name, both strings are stored. Mass evidence is what links them, not an assumption that the codes are interchangeable.
The search block records the instrument title in the publisher's words, the consultation date, any version or page identifier supplied by the publisher, and the name of the person who searched. Synonyms are separate lines: sequence name, salt name, fragment name and any legacy code. Each line is coded no entry located, entry located, or wording unclear. "No entry located" is valid only for the string that was typed. An entry that is located is quoted rather than paraphrased, and the quote is long enough to include exceptions and definitions. Wording that is unclear forces a hold. Absence is never inferred from a synonym that was not searched.
The analytical cross-check points to file identifiers instead of repeating a purity percentage. Minimum pointers are the HPLC sample name, the chromatogram identifier, the intact-mass result identifier and the related-substance specification row. The reviewer signs that those identifiers belong to the header lot. Where dual review is required, a second person signs that the quoted wording was compared with the identity block, not with memory of a similar peptide. Disagreement is coded not determined.
Keep the record for the same period as the batch documentation for that lot. If the search is repeated because a list may have changed, add a new row. Do not overwrite the row that accompanied original receipt. The form stays inside the research record and links identity evidence to a quoted instrument and a coded result. It is not a permit, a tariff ruling, a possession approval, or a method for moving goods. The acceptance criterion is completeness: identity linked, instrument named, extract quoted, synonyms listed, result coded and reviewer signed. An incomplete form is not a pass.
Frequently asked questions
Does a research-use label decide status on a prohibited-imports list?
No. A research-use statement limits the scope of supply. It does not classify goods under a border instrument. Status follows the official wording, the identified substance and any condition that instrument sets. Record the instrument, the date and each synonym searched. Do not treat a vial label, a catalogue heading or a dispatch note as a legal determination. This page is not that determination.
Is a sporting or equine prohibited list the same as a customs import list?
No. They are separate instruments. Australian Prescriber commentary on the WADA Prohibited List, and debate about the FEI progressive list, show list-specific argument. Neither source is an Australian Border Force schedule. A hit or a miss on a sporting or equine list must not auto-fill an import column. Keep a separate date, a separate quoted extract and a separate reviewer sign-off for each instrument consulted.
Can an HPLC purity percentage show that a peptide is outside a prohibited list?
No. Area-percent purity describes a chromatogram under a stated method, wavelength and reporting threshold. It does not name a legal entry and it does not replace intact-mass identity. Keep HPLC purity, related substances and net peptide content as analytical rows. Use the official instrument, quoted and dated, for list status. If the mass does not match the labelled sequence, do not sign a list result. Hold the lot for identity work.
Does holding a lot in Australia decide prohibited-import status?
No. A domestic receipt can show which lot, certificate and consignment were on file. It does not classify the substance under a border instrument, and it does not remove any duty to read the current official instrument before relying on a list result. A foreign shipment is a different record type. This page does not explain import entries, permits or declaration wording.
What should a buyer do with a claim that a peptide is not prohibited?
Do not rely on the sentence unless the supplier provides a dated extract from the official instrument, in the publisher's words, matched to the same substance name and salt form as the lot. If that extract is missing, remove the claim from the reliance set, keep the analytical file, and code list status as not determined until a qualified check is written down. A certificate of analysis is not that check. This article is not that check.
Does this article reproduce the Australian Border Force prohibited imports list?
No. The supplied literature does not contain an official prohibited-imports schedule, and this page does not invent one. Consult the current official instrument directly, and file a dated extract with the lot record. Search sequence name, salt name and legacy codes as separate strings before recording an absence. Trade names are not a complete search. Research materials discussed here are not for human use. This page does not advise that any peptide may be imported, possessed or supplied.
References
- DOI:10.1080/00050066908257667 — Prohibited importation of professional literature — Australian Psychologist — 1969
- DOI:10.18773/austprescr.2016.032 — Comment: Meldonium and the WADA Prohibited List — Australian Prescriber — 2016
- DOI:10.21836/pem20100225 — The „progressive list“ - the controversy about the FEI list of prohibited substances — Pferdeheilkunde Equine Medicine — 2010
- DOI:10.1111/j.1467-8462.1970.tb00090.x — Australian Imports during the 1960s — Australian Economic Review — 1970
- DOI:10.1021/cen-v048n044.p048 — Australian chemicals: growth or imports? — Chemical & Engineering News Archive — 1970
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
